发明名称 Tetrazine derivatives
摘要 [ 3H]-Imidazo[ 5,1-d] -1,2,3,5-tetrazin-4-one derivatives of the formula: <IMAGE> wherein R1 represents hydrogen, or an alkyl, alkenyl or alkynyl group containing up to 6 carbon atoms, each such group being unsubstituted or substituted by from one to three substituents selected from halogen atoms, alkoxy, alkylthio, alkylsulphinyl and alkylsulphonyl groups containing up to 4 carbon atoms, and optionally substituted phenyl groups, or R1 represents a cycloalkyl group containing from 3 to 8 carbon atoms, and R2 represents a carbamoyl group optionally N-substituted by one or two groups selected ftom alkyl and alkenyl groups containing up to 4 carbon atoms, and cycloalkyl groups containing 3 to 8 carbon atoms, are new therapeutically useful compounds possessing antineoplastic and immunomodulatory activity.
申请公布号 US5260291(A) 申请公布日期 1993.11.09
申请号 US19910781020 申请日期 1991.10.18
申请人 CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED 发明人 LUNT, EDWARD;STEVENS, MALCOLM F. G.;STONE, ROBERT;WOOLDRIDGE, KENNETH R. H.;NEWLANDS, EDWARD S.
分类号 A61K31/52;C07D487/04;(IPC1-7):A61K31/415;C07P487/04 主分类号 A61K31/52
代理机构 代理人
主权项
地址